HealthDay on MSN1 小时
GLP-1 weight-loss drugs might help protect kidneys
In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...
West Virginia residents struggle to afford GLP-1 weight loss drugs after state ends subsidy ...
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
Biden will move to have Medicare, Medicaid cover GLP-1 weight-loss meds
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...
Allurion launches compounded GLP-1 program as FDA aims to end access
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.Cmvv_fHs.js ...
GlobalData on MSN7 小时
Allurion launches AI weight loss support GLP-1 drug programme
Now available in the US, AllurionMeds aims to address common concerns around the use and affordability of GLP-1 weight loss ...
5 GLP-1 marketing trends as brands jump on weight loss drug craze
As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.
Losing Weight With Ozempic Might Also Lighten Your Bar Tab, Study Finds
A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...
STAT20 小时
Inside the telehealth-fueled GLP-1 alternative market
The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...
拥抱881亿美元市场，国产GLP-1创新药出海值得期待
智通财经APP获悉，数据显示，全球市场对于GLP-1减肥药物有着巨大的需求。截至2022年，全球GLP-1受体激动剂(糖尿病+减重)整体市场规模突破200亿美元，预计2024年，这一市场规模将达到423亿美元，到2030年，这一市场规模有望进一步增长至881亿美元。 不过有分析人士指出，从目前诺和诺德及礼来的三季度销售数据来看，GLP-1受体激动剂(糖尿病+减重)实际规模或可能超出上述预期。数据显 ...